|
|
Volumn 2, Issue 4, 2000, Pages 313-315
|
|
Clinical trials for the treatment of systemic onset juvenile rheumatoid arthritis-juvenile idiopathic arthritis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FORECASTING;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
JUVENILE RHEUMATOID ARTHRITIS;
ORAL DRUG ADMINISTRATION;
PILOT STUDY;
SUBCUTANEOUS DRUG ADMINISTRATION;
TIME;
ADMINISTRATION, ORAL;
ADRENAL CORTEX HORMONES;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, JUVENILE RHEUMATOID;
BONE MARROW TRANSPLANTATION;
CHILD;
CLINICAL TRIALS;
CONTROLLED CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
FORECASTING;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
INJECTIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
PILOT PROJECTS;
PLACEBOS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TIME FACTORS;
|
|
EID: 0034252055
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-000-0068-9 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
